comparemela.com

Latest Breaking News On - Jenavalve technology - Page 1 : comparemela.com

After DanGer Shock s Win in AMICS for Impella: What s Next?

Novel transcatheter heart valve may be effective for management of high-risk aortic regurgitation

1. The 30-day composite primary safety endpoint of > 40.5% was achieved for Trilogy TAVI. 2. 8% of patients who underwent Trilogy TAVI had passed at the 1-year follow-up. Evidence Rating Level: 1 (Excellent) Study Rundown: Surgery remains the primary intervention for native aortic regurgitation, but high-risk patients lack optimal alternatives. Traditional transcatheter heart valves

The future health risks of adverse pregnancy outcomes … and other research

Ann Robinson reviews the latest research Pregnancy and childbirth can be worrying times, and the news that adverse pregnancy outcomes are associated with an increased risk of dying younger will ramp up anxiety, but it also offers scope to shift the dial. This national Swedish cohort study of more than two million women found that any of five major adverse pregnancy outcomes (preterm delivery, small for gestational age, pre-eclampsia, other hypertensive disorders, and gestational diabetes) was associated with increased mortality risks that remained elevated up to 46 years later. The major causes of death included cardiovascular and respiratory disorders and diabetes. Pregnancy has been called a “natural stress test” that unmasks future health risks. But are these pre-existing risks that were going to play out anyway or are they new risks? This study suggests the latter. It used co-sibling data and found that familial factors (genetic and environmental) accounted for only a small

Transfemoral transcatheter aortic valve replacement for pure aortic regurgitation

Transfemoral transcatheter aortic valve replacement for pure aortic regurgitation
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

egnite, Inc and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference

egnite, Inc and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.